EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Fibrotic Remodeling in Retinal Vascular Diseases: Cellular Origins, Molecular Mechanisms, and Therapeutic Perspectives

Jia Yu Ning iD, Brian Wang, Miyuki Ishida Yamamoto, Kaori H Yamada iD

Cells · 2026

DOI: 10.3390/cells15191772 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Jia Yu Ning und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Regenerative Medicine, University of Illinois College of Medicine, Chicago, IL 60612, USA. Hauptthemen laut MEDLINE: Retinal Diseases. Die Arbeit nennt 347 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NCI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrosis is a major vision-threatening complication of neovascular retinal diseases, including neovascular age-related macular degeneration (nAMD) and proliferative diabetic retinopathy (PDR). Although vascular endothelial growth factor (VEGF) inhibition effectively suppresses vascular leakage and neovascularization, some patients still develop fibrosis and experience irreversible vision loss. Recent studies have identified multiple interconnected signaling pathways that contribute to fibrotic progression, highlighting the potential need for combination or multitargeted therapeutic strategies. This review summarizes the cellular origins of myofibroblasts, the molecular mechanisms underlying fibrosis, and recent advances in antifibrotic therapies. We particularly highlight the angio-fibrotic switch, mesenchymal transition, cellular stress responses, extracellular matrix remodeling, mechanotransduction, and emerging therapeutic approaches for ocular fibrosis. Relevant preclinical and clinical studies were identified through searches of PubMed and clinical trial registries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal DiseasesHumansAnimalsFibrosisDiabetic RetinopathyMacular DegenerationSignal Transduction

Stichwörter der Autor:innen

fibrosisneovascular age-related macular degenerationproliferative diabetic retinopathy

Autor:innen und Institutionen

  • Department of Pharmacology and Regenerative Medicine, University of Illinois College of Medicine, Chicago, IL 60612, USA.
  • Department of Ophthalmology and Visual Sciences, University of Illinois College of Medicine, Chicago, IL 60612, USA.

ORCID-Profile: Jia Yu Ning, Kaori H Yamada

Förderung

  • NEI NIH HHS
  • NCI NIH HHS
  • NIH HHS
  • American Cancer Society
  • National Institutes of Health

Zitieren

APA

Ning, J. Y., Wang, B., Yamamoto, M. I., & Yamada, K. H. (2026). Fibrotic Remodeling in Retinal Vascular Diseases: Cellular Origins, Molecular Mechanisms, and Therapeutic Perspectives. Cells. https://doi.org/10.3390/cells15191772

Vancouver

Ning JY, Wang B, Yamamoto MI, Yamada KH. Fibrotic Remodeling in Retinal Vascular Diseases: Cellular Origins, Molecular Mechanisms, and Therapeutic Perspectives. Cells. 2026. doi:10.3390/cells15191772

BibTeX
@article{Ning2026,
  author = {Ning, Jia Yu and Wang, Brian and Yamamoto, Miyuki Ishida and Yamada, Kaori H},
  title = {Fibrotic Remodeling in Retinal Vascular Diseases: Cellular Origins, Molecular Mechanisms, and Therapeutic Perspectives},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15191772}
}
Kostenlos starten →